Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
16 participants
OBSERVATIONAL
2011-09-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardio and Renovascular Effects of Isometric Exercise in the Healthy Human Measured by PET/CT and MRI
NCT06555211
Evaluation of Elastic Properties of Ascending Aorta
NCT05252143
Assessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media Thickness
NCT00001904
Whole Body Magnetic Resonance Angiography in Ischemic Patients
NCT00538408
Development of 3T Magnetic Resonance Research Methods for NIA Studies
NCT01324206
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To determine conductivities and permittivities in the spectral region from 1 KHz to 1 MHz for persons with: (a) a normal distribution of fat and muscles, (b) exceptionally thick layers of subcutaneous fat, and (c) exceptionally thin layers of subcutaneous fat. Both sexes should be represented.
2. To verify that temporal variations synchronous with the heartbeat could be measured on all three groups.
Hypotheses:
A. That experimentally in vivo determined electrical parameters for tissues would differ considerably from theoretical values and from values measured in vitro experiments.
B. That the variations of the electrical parameters would exhibit little variation from person to person.
C. Those simple experimental relations can be established for the electrical parameters by including a simple vascularization model.
D. That it is possible to measure temporal variation of the impedance, which are synchronous with the heartbeat.
E. That the measured values would facilitate the calculation of the differential blood pressure with accuracies better than 10 mmHg.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bioimpedance
8 females and 8 males BMI from 19 to 46 SBP from 119 to 182
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mental ability to understand information to test subjects
Exclusion Criteria
* Allergic reactions to ECG or EMG electrodes
* Mentally unstable or unable to perceive instructions
* Metal implants
* Claustrophobia
* Disqualified for MR scanning
* Pregnant
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Sense A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lars Lading, Prof.
Role: STUDY_DIRECTOR
Sense A/S
Tine W Hansen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Rigshospitalet (Copenhagen Univ. Hospital)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rigshopsitalet (Copenhagen Univ. Hospital)
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-1-2011-076
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.